Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2019 Apr;25(4):699-711. doi: 10.1016/j.bbmt.2018.11.004. Epub 2018 Nov 10.

PMID:
30423480
2.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE.

Haematologica. 2019 Apr;104(4):844-854. doi: 10.3324/haematol.2018.200121. Epub 2018 Oct 31.

3.

A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.

Litzow MR, Wang XV, Carroll MP, Karp JE, Ketterling RP, Zhang Y, Kaufmann SH, Lazarus HM, Luger SM, Paietta EM, Pratz KW, Tun HW, Altman JK, Broun ER, Rybka WB, Rowe JM, Tallman MS.

Am J Hematol. 2019 Jan;94(1):111-117. doi: 10.1002/ajh.25333. Epub 2018 Nov 15.

PMID:
30370956
4.

Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma.

Caparelli ML, Roberts NJ, Braverman TS, Stevens RM, Broun ER, Allamaneni S.

World J Hepatol. 2016 Aug 18;8(23):994-8. doi: 10.4254/wjh.v8.i23.994.

5.

Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.

Shiau S, Broun EC, Arpadi SM, Yin MT.

AIDS. 2013 Jul 31;27(12):1949-57. doi: 10.1097/QAD.0b013e328361d241. Review.

6.

High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma.

Thomas TA, Broun EC, Abildskov KM, Kubin CJ, Horan J, Yin MT, Cremers S.

Ther Drug Monit. 2012 Aug;34(4):398-405. doi: 10.1097/FTD.0b013e31825c827a.

7.

Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue.

Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J.

Endocrinology. 2009 Feb;150(2):651-61. doi: 10.1210/en.2008-1118. Epub 2008 Oct 9.

8.

Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.

Milsom MD, Jerabek-Willemsen M, Harris CE, Schambach A, Broun E, Bailey J, Jansen M, Schleimer D, Nattamai K, Wilhelm J, Watson A, Geiger H, Margison GP, Moritz T, Baum C, Thomale J, Williams DA.

Cancer Res. 2008 Aug 1;68(15):6171-80. doi: 10.1158/0008-5472.CAN-08-0320.

10.

Use of the anti-idiotype breast cancer vaccine 11D10 in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.

Reece DE, Foon KA, Bhattarcharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, Dipersio JF, Holland HK, Howard DA, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL.

Clin Breast Cancer. 2003 Feb;3 Suppl 4:S152-7.

PMID:
12620153
11.

Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.

Reece DE, Foon KA, Battacharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, Dipersio JF, Holland HK, Howard DS, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL.

Clin Breast Cancer. 2001 Apr;2(1):52-8.

PMID:
11899383
12.

Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.

Ayash LJ, Clarke M, Silver SM, Braun T, Uberti J, Ratanatharathorn V, Reynolds C, Ferrara J, Broun ER, Adams PT.

Bone Marrow Transplant. 2001 May;27(9):939-47. Review.

13.

Longitudinal study of adaptation to the stress of bone marrow transplantation.

Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER.

J Clin Oncol. 2000 Apr;18(7):1539-49.

PMID:
10735903
14.

Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells.

Cornetta K, Gharpure V, Mills B, Hromas R, Abonour R, Broun ER, Traycoff CM, Hanna M, Wyman N, Danielson C, Gonin R, Kunkel LK, Oldham F, Srour EF.

Bone Marrow Transplant. 1998 Jan;21(1):65-71.

15.

Oral cavity complications of bone marrow transplantation.

Eisen D, Essell J, Broun ER.

Semin Cutan Med Surg. 1997 Dec;16(4):265-72. Review.

PMID:
9421217
16.

Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trial.

Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, Broun ER, Bayer RA, Wyres M, Hill J, Jelaca-Maxwell K, Nichols CR, Brown SL, Nimer SD, Gabrilove J.

Blood. 1997 May 1;89(9):3136-47.

17.

Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.

Broun ER, Nichols CR, Gize G, Cornetta K, Hromas RA, Schacht B, Einhorn LH.

Cancer. 1997 Apr 15;79(8):1605-10.

PMID:
9118046
18.

A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.

Broun ER, Iseminger KA, Rose PG, Lentz SL, Malfetano JH, Lincoln S, Mannel R.

Am J Clin Oncol. 1997 Feb;20(1):78-80.

PMID:
9020294
19.

Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation.

Rigden JP, Cornetta K, Srour EF, Hanna M, Broun ER, Hromas R, Baute J, Hilton J, Cox E, Rubin L, Gonin R, Tricot G.

Bone Marrow Transplant. 1996 Nov;18(5):913-9.

PMID:
8932845
20.

Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia.

Cornetta K, Srour EF, Moore A, Davidson A, Broun ER, Hromas R, Moen RC, Morgan RA, Rubin L, Anderson WF, Hoffman R, Tricot G.

Hum Gene Ther. 1996 Jul 10;7(11):1323-9.

PMID:
8818719
21.

Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.

Broun ER, Nichols CR, Mandanas R, Salzman D, Turns M, Hromas R, Cornetta K, Einhorn LH.

Bone Marrow Transplant. 1995 Sep;16(3):353-8.

PMID:
8535306
22.

Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections.

Blanke C, Clark C, Broun ER, Tricot G, Cunningham I, Cornetta K, Hedderman A, Hromas R.

Am J Med. 1995 Sep;99(3):326-8. No abstract available.

PMID:
7653496
23.

Tandem autotransplantation for the treatment of metastatic breast cancer.

Broun ER, Sridhara R, Sledge GW, Loesch D, Kneebone PH, Hanna M, Hromas R, Cornetta K, Einhorn LH.

J Clin Oncol. 1995 Aug;13(8):2050-5.

PMID:
7636548
24.

A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study.

Broun ER, Iseminger KA, Bookman M.

Am J Clin Oncol. 1995 Apr;18(2):164-6.

PMID:
7900709
25.

Autologous bone marrow transplantation.

McCarthy LJ, Danielson CF, Cornetta K, Srour EF, Broun ER.

Crit Rev Clin Lab Sci. 1995;32(1):67-119. Review.

PMID:
7748468
26.

Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation.

Hromas R, Clark C, Blanke C, Tricot G, Cornetta K, Hedderman A, Broun ER.

Bone Marrow Transplant. 1994 Oct;14(4):663-4. No abstract available.

PMID:
7858548
27.

Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation.

Hromas R, Cornetta K, Srour E, Blanke C, Broun ER.

Blood. 1994 Sep 1;84(5):1689-90. No abstract available.

28.

Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot study.

Broun ER, Belinson JL, Berek JS, McIntosh D, Hurd D, Ball H, Williams S.

Gynecol Oncol. 1994 Aug;54(2):142-6.

PMID:
8063237
29.

Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.

Broun ER, Nichols CR, Turns M, Williams SD, Loehrer PJ, Roth BJ, Lazarus HM, Einhorn LH.

Cancer. 1994 Mar 15;73(6):1716-20.

PMID:
7512438
30.

Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.

Broun ER, Wheat JL, Kneebone PH, Sundblad K, Hromas RA, Tricot G.

Antimicrob Agents Chemother. 1994 Mar;38(3):576-9.

31.

High-dose carboplatin and mitoxantrone with autologous bone marrow support in the treatment of advanced breast cancer.

Broun ER, Sledge GW, Einhorn LH, Tricot GJ.

Am J Clin Oncol. 1993 Feb;16(1):9-13.

PMID:
8424413
32.

Dose intensity in germ cell cancer: continued lessons from a model neoplasm.

Nichols CR, Roth BJ, Broun ER, Loehrer PJ, Williams SD, Einhorn LH.

Eur Urol. 1993;23(1):231-8; discussion 239. Review.

PMID:
8386654
33.

Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.

Broun ER, Nichols CR, Kneebone P, Williams SD, Loehrer PJ, Einhorn LH, Tricot GJ.

Ann Intern Med. 1992 Jul 15;117(2):124-8.

PMID:
1318648
34.

Retroviral-mediated gene transfer of bone marrow cells during autologous bone marrow transplantation for acute leukemia.

Cornetta K, Tricot G, Broun ER, Hromas R, Srour E, Hoffman R, Anderson WF, Moen RC, Morgan RA.

Hum Gene Ther. 1992 Jun;3(3):305-18. No abstract available.

PMID:
1643150
35.

Expanding role of the bone marrow processing laboratory.

Graves VL, Danielson CF, Broun ER, Tricot G, McCarthy LJ.

Prog Clin Biol Res. 1992;377:373-8. No abstract available.

PMID:
1438433
36.
37.

High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors.

Broun ER, Nichols CR, Tricot G, Loehrer PJ, Williams SD, Einhorn LH.

Bone Marrow Transplant. 1991 Jan;7(1):53-6.

PMID:
1646050
38.

Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression.

Broun ER, Greist A, Tricot G, Hoffman R.

JAMA. 1990 Sep 19;264(11):1441-3.

PMID:
2094240
39.

Spontaneous remission in myelodysplastic syndrome. A case report.

Broun ER, Heerema NA, Tricot G.

Cancer Genet Cytogenet. 1990 May;46(1):125-8.

PMID:
2331675
40.

Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation.

Broun ER, Tricot G, Akard L, Nichols C, Cheerva A, Jansen J.

Bone Marrow Transplant. 1990 May;5(5):341-4.

PMID:
2190660

Supplemental Content

Support Center